Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience
Turkish Journal of Medical Sciences · 16.06.2026 · 56 (3) · 718-729
DOI: 10.55730/1300-0144.6205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 16.06.2026. Verfasst von Ümran Gül und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Etlik City Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: Acromegaly. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: This study aimed to evaluate the demographic, clinical, and hormonal characteristics; comorbidities; surgical pathology; treatment modalities; and long-term clinical outcomes of patients diagnosed with and managed for acromegaly at our tertiary referral center over a 15-year period. Materials and methods: Between 2010 and 2024, 247 patients with acromegaly were evaluated. Diagnosis and biochemical remission were determined according to the 2024 Acromegaly Consensus Criteria.
Results
The median follow-up duration was 8 years (IQR: 3–14). At the time of diagnosis, the most frequent pituitary hormone deficiency was secondary adrenal insufficiency, present in 17.8% of patients. The most common comorbidities were hypertension (HT, 42.1%) and diabetes mellitus (DM, 30.8%). At the time of diagnosis, macroadenomas were present in 153 of 193 patients (79.3%), and, according to the Knosp classification, 28.6% of tumors were grade 4. A total of 218 patients underwent surgical intervention; 86 (39.4%) achieved postoperative cure without the need for adjuvant medical therapy or radiotherapy. Postoperatively, one or more anterior pituitary hormone deficiencies were found in 34 patients (22.8%), with central hypothyroidism being the most common (52.9%). Patients who achieved biochemical remission were significantly older (p = 0.003), had a higher prevalence of HT and DM (both p < 0.05), and were more likely to exhibit positive growth hormone (GH) immunostaining (p = 0.017). In contrast, those who did not achieve remission were more likely to have higher Knosp grades (3–4) (p = 0.002).
Conclusions
In this study, a favorable prognosis was associated with older age at diagnosis, lower baseline GH levels, positive GH immunostaining, smaller tumor size, and lower Knosp grade, underscoring the prognostic value of both biochemical and anatomical parameters. Further studies are warranted to refine prognostic markers and establish standardized treatment algorithms to improve long-term outcomes in acromegaly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Etlik City Hospital, Ankara, Turkiye.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Çanakkale Mehmet Akif Ersoy State Hospital, Çanakkale, Turkiye.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical Park Hospital, Antalya, Turkiye.
- Department of Neurosurgery, Etlik City Hospital, Ankara, Turkiye.
ORCID-Profile: Ümran Gül, Bekir Uçan, Hayri Bostan, Hakan Düğer, Hayri Kertmen, Caner Ünlüer, Halil Durantaş, Oğulcan Boz, Ceren Karaçalik Ünver, Burak Menekşe, Sema Hepşen, İlknur Öztürk Ünsal, Mustafa Özbek, Erman Çakal, Muhammed Kizilgül
Zitieren
APA
Gül, Ü., Uçan, B., Bostan, H., Düğer, H., Kertmen, H., Ünlüer, C., Durantaş, H., Boz, O., Karaçalik Ünver, C., Menekşe, B., Hepşen, S., Öztürk Ünsal, İ., Özbek, M., Çakal, E., & Kizilgül, M. (2026). Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience. Turkish Journal of Medical Sciences, 56(3), 718-729. https://doi.org/10.55730/1300-0144.6205
Vancouver
Gül Ü, Uçan B, Bostan H, Düğer H, Kertmen H, Ünlüer C, et al. Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience. Turkish Journal of Medical Sciences. 2026;56(3):718-729. doi:10.55730/1300-0144.6205
BibTeX
@article{Gl2026,
author = {Gül, Ümran and Uçan, Bekir and Bostan, Hayri and Düğer, Hakan and Kertmen, Hayri and Ünlüer, Caner and Durantaş, Halil and Boz, Oğulcan and Karaçalik Ünver, Ceren and Menekşe, Burak and Hepşen, Sema and Öztürk Ünsal, İlknur and Özbek, Mustafa and Çakal, Erman and Kizilgül, Muhammed},
title = {Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience},
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {3},
pages = {718--729},
doi = {10.55730/1300-0144.6205}
}
EUVIMED